18 / 18
ZARTAN 50, 100 mg.
Each tablet contains 50, 100 mg losartan potassium respectively. S3 A41/7.1.3/0287, 0289. NAM NS2 08/7.1.3/0067, 0086. For full prescribing information, refer to the professional information
approved by SAHPRA, 31 August 2019.
ZARTAN CO 50/12,5, 100/25.
Each tablet contains 50, 100 mg losartan potassium and 12,5, 25 mg hydrochlorothiazide respectively. S3 A42/7.1.3/1068, 1069. NAM NS2
12/7.1.3/0070, 0071. For full prescribing information, refer to the professional information approved by SAHPRA, 31 July 2019.
1)
Dahlöf B,
et al.
Cardiovascular morbidity and mortality in losartan intervention for endpoint
reduction in hypertension study (LIFE): a randomised trial against atenolol.
The Lancet
2002;359:995-1003.
2)
Brenner BM,
et al.
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes
and nephropathy.
N Engl J Med
2001;345(12):861-869.
3)
Pitt B,
et al.
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE).
Lancet
1997;349:747–52.
4)
Database of Medicine Prices (12 March 2021). Department of Health website.
http://www.mpr.gov.za.
ZNCH730/05/2021.
holds rank
in hypertension
Effective BP lowering with an
ARB at an affordable price.
1,2,3,4
MORE
AFFORDABLE
THAN THE
ORIGINATOR
4
UP TO
32
%
MORE
AFFORDABLE
THAN THE
ORIGINATOR
4
UP TO
43
%
For further product information contact
PHARMA DYNAMICS
P O Box 30958 Tokai Cape Town 7966
Fax
+27 21 701 5898
CUSTOMER CARE LINE
0860 PHARMA (742 762) / +27 21 707 7000
www.pharmadynamics.co.za